About Innule Biosciences
Innule Biosciences is a Healthcare company based in Bengaluru (India) founded in 2020 by Koteppa Pari. It operates as a recombinant proteins, custom proteins, and insulin products are produced. Its Indian entity Innule Biosciences Private Limited reported revenue of ₹12.5 Lakh. Innule Biosciences offers products and services including Recombinant Proteins, Custom Made Proteins, Insulins and Analogues, and Isotope Labeled Proteins. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Drug Development. Its competitors include Enzene Biosciences, Hybio Pharmaceutical, AmbioPharm, Ocelot Bio and PolyPeptide and 4 more; 6 of its 9 listed competitors have raised funding.
Company details
Innule Biosciences was founded in 2020 and is based in Bengaluru, India. Operations center on the production of recombinant proteins, enzymes, custom-made proteins, insulins, and insulin analogues within the biotechnology sector. Research-based products for the life sciences industry are developed. The privately held company is supported by venture capital funding.
- Headquarters Bengaluru, India
- Founders Koteppa Pari
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website innulebio.in
- Legal Name Innule Biosciences Private Limited
- Date of Incorporation 15 Jan, 2020
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹12.5 Lakh
FY 2024 · -17% YoY
- Net Loss-₹40,840
FY 2024 · -3% margin
- EBITDA-₹42,520
FY 2024 · -3% margin
Associated legal entities of Innule Biosciences
Innule Biosciences operates through Innule Biosciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Innule Biosciences Private Limited CIN U24231KA2020PTC131629 | Active | 15 Jan 2020 | Bangalore, Karnataka | ₹0.1 Cr | – | 2 | View details |
Products & Services of Innule Biosciences
Innule Biosciences offers a comprehensive portfolio of products and services, including Recombinant Proteins, Custom Made Proteins, Insulins and Analogues, and Isotope Labeled Proteins.
Engineered proteins for research and industrial applications
Tailored proteins for specific client needs
Proteins for medical and research purposes
Labeled peptides for advanced scientific studies
Board of directors of Innule Biosciences Private Limited (Innule Biosciences)
Innule Biosciences Private Limited is the primary company behind Innule Biosciences. The board of Innule Biosciences Private Limited currently have 2 directors; the longest-serving is Koteppa Pari, appointed in 2020.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Koteppa Pari DIN 08669302 | Director | 15 Jan 2020 | 6 yrs 9 mo | Innule Biosciences Private Limited |
| Pari Veerappa DIN 08669343 | Director | 15 Jan 2020 | 6 yrs 9 mo | Innule Biosciences Private Limited |
People of Innule Biosciences
1 people are tracked at Innule Biosciences (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Founder | Leadership |
Complete people profiles for Innule Biosciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Innule Biosciences
Figures of Innule Biosciences Private Limited, the primary company behind Innule Biosciences, for FY 2024. Revenue was ₹12.5 Lakh (-17% year on year). Net loss was -₹40,840 (-3% margin). EBITDA was -₹42,520 (-3% margin). Revenue has grown at a compounded annual rate of -6% over three years.
- ₹12.5 LakhRevenue · FY 2024 · -17% YoY
- -₹40,840Net loss · -3% margin
- -₹42,520EBITDA · -3% margin
- ₹52,630Paid-up capital
- -6%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Innule Biosciences Private Limited are on its company page.
Detailed financial statements for Innule Biosciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Innule Biosciences
Innule Biosciences has 9 listed competitors in our database, 6 of them funded. They include Enzene Biosciences, Hybio Pharmaceutical, AmbioPharm, Ocelot Bio and PolyPeptide, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| enzene.com | 2006 | Pune, India | $50M | 10 | Company specializing in development of Biosimilars | |
| hybio.com.cn | 1998 | Shenzhen, China | $15M | – | Polypeptide drugs and APIs are developed and manufactured. | |
| ambiopharm.com | 2006 | North Augusta, United States | $24M | 186 | CDMO and analytical services for peptide development are provided. | |
| ocelotbio.com | 2020 | San Diego, United States | $36M | – | Ocelot Bio is a CDMO specializing in peptide manufacturing services. | |
| polypeptide.com | 1952 | Baar, Switzerland | – | – | Proprietary, GMP-grade, and non-GMP peptides are manufactured by PolyPeptide Labs. | |
| maruho.co.jp | 1915 | Osaka, Japan | – | – | Conducts R&D and manufactures ethical drugs for healthcare applications. | |
| aperiambio.com | 2019 | United States | $13M | – | Industrial and therapeutic proteins are manufactured by Aperiam Bio. | |
| vivitide.com | 1983 | Gardner, United States | – | 94 | Drug development services for neoantigen peptides and antibodies are provided. | |
| micot.cn | 2007 | China | $72.16M | – | Drug R&D services for cardiovascular and metabolic diseases are provided. |
Detailed competitors of Innule Biosciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as Innule Biosciences (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Innule Biosciences
Innule Biosciences was founded in 2020.
Innule Biosciences is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
The primary company behind Innule Biosciences, Innule Biosciences Private Limited, reported revenue of ₹12.5 Lakh for FY 2024, down 17% year on year.
Innule Biosciences was founded in 2020 and is based in Bengaluru, India. Operations center on the production of recombinant proteins, enzymes, custom-made proteins, insulins, and insulin analogues within the biotechnology sector. Research-based products for the life sciences industry are developed. The privately held company is supported by venture capital funding.
Innule Biosciences's top competitors include Enzene Biosciences, Hybio Pharmaceutical and PolyPeptide.
Innule Biosciences offers Recombinant Proteins, Custom Made Proteins, Insulins and Analogues, and Isotope Labeled Proteins.
Innule Biosciences operates through Innule Biosciences Private Limited.
The legal entities of Innule Biosciences currently have 2 directors, including Koteppa Pari, Pari Veerappa.